• Something wrong with this record ?

Artichoke Leaf Extract Inhibits AKR1B1 and Reduces NF-κB Activity in Human Leukemic Cells

I. Miláčková, K. Kapustová, P. Mučaji, J. Hošek,

. 2017 ; 31 (3) : 488-496. [pub] 20170126

Language English Country England, Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc17023335

The human intracellular enzyme AKR1B1 belongs to the aldo-keto reductase superfamily. The AKR1B1-catalyzed reduction of aldehydes is part of the intracellular inflammatory pathway leading to the activation of NF-κB and the expression of pro-inflammatory genes. The present study is aimed at determining the inhibition of AKR1B1 brought about by an extract of artichoke leaves (bracts), and the effects of this extract and three participating compounds on the expression of AKR1B1, COX-2, and MMP-2 proteins in THP-1 cells. It seeks to identify the ability of the test substances to modulate the lipopolysaccharide (LPS)-induced activation of NF-κB in cells and the intracellular oxidant effect of test substances after incubation with LPS. Low concentrations of the extract inhibit the enzyme AKR1B1. After stimulation by LPS, the extract attenuated the activity of NF-κB in THP-1 cells, but no changes in the expression of AKR1B1 were recorded. The extract diminished the expression of the inflammation-related enzymes COX-2 and MMP-2, probably by inhibiting the activity of NF-κB. The extract significantly diminished the intracellular reactive oxygen species after a brief LPS incubation, which may also have reduced intracellular inflammation. The diminished activity of NF-κB in the cells could be linked to the inhibition of the activity of AKR1B1. Copyright © 2017 John Wiley & Sons, Ltd.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023335
003      
CZ-PrNML
005      
20170906120213.0
007      
ta
008      
170720s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ptr.5774 $2 doi
035    __
$a (PubMed)28127803
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Miláčková, Ivana $u Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, SR-83232, Bratislava, Slovakia.
245    10
$a Artichoke Leaf Extract Inhibits AKR1B1 and Reduces NF-κB Activity in Human Leukemic Cells / $c I. Miláčková, K. Kapustová, P. Mučaji, J. Hošek,
520    9_
$a The human intracellular enzyme AKR1B1 belongs to the aldo-keto reductase superfamily. The AKR1B1-catalyzed reduction of aldehydes is part of the intracellular inflammatory pathway leading to the activation of NF-κB and the expression of pro-inflammatory genes. The present study is aimed at determining the inhibition of AKR1B1 brought about by an extract of artichoke leaves (bracts), and the effects of this extract and three participating compounds on the expression of AKR1B1, COX-2, and MMP-2 proteins in THP-1 cells. It seeks to identify the ability of the test substances to modulate the lipopolysaccharide (LPS)-induced activation of NF-κB in cells and the intracellular oxidant effect of test substances after incubation with LPS. Low concentrations of the extract inhibit the enzyme AKR1B1. After stimulation by LPS, the extract attenuated the activity of NF-κB in THP-1 cells, but no changes in the expression of AKR1B1 were recorded. The extract diminished the expression of the inflammation-related enzymes COX-2 and MMP-2, probably by inhibiting the activity of NF-κB. The extract significantly diminished the intracellular reactive oxygen species after a brief LPS incubation, which may also have reduced intracellular inflammation. The diminished activity of NF-κB in the cells could be linked to the inhibition of the activity of AKR1B1. Copyright © 2017 John Wiley & Sons, Ltd.
650    _2
$a aldehydreduktasa $x antagonisté a inhibitory $x genetika $x metabolismus $7 D000449
650    _2
$a zvířata $7 D000818
650    _2
$a kultivované buňky $7 D002478
650    _2
$a cyklooxygenasa 2 $x metabolismus $7 D051546
650    _2
$a Cynara scolymus $x chemie $7 D031943
650    _2
$a down regulace $x účinky léků $7 D015536
650    _2
$a regulace genové exprese $x účinky léků $7 D005786
650    _2
$a lidé $7 D006801
650    _2
$a zánět $x chemicky indukované $x genetika $x metabolismus $7 D007249
650    _2
$a leukemie $x genetika $x metabolismus $x patologie $7 D007938
650    _2
$a lipopolysacharidy $7 D008070
650    _2
$a matrixová metaloproteinasa 2 $x genetika $x metabolismus $7 D020778
650    _2
$a rostlinné extrakty $x farmakologie $7 D010936
650    _2
$a listy rostlin $x chemie $7 D018515
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a signální transdukce $x účinky léků $x genetika $7 D015398
650    _2
$a transkripční faktor RelA $x antagonisté a inhibitory $x metabolismus $7 D051996
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kapustová, Kristína $u Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, SR-83232, Bratislava, Slovakia.
700    1_
$a Mučaji, Pavel $u Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, SR-83232, Bratislava, Slovakia.
700    1_
$a Hošek, Jan $u Department of Molecular Biology and Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého tř. 1946/1, CZ-61242, Brno, Czech Republic.
773    0_
$w MED00003832 $t Phytotherapy research PTR $x 1099-1573 $g Roč. 31, č. 3 (2017), s. 488-496
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28127803 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170906120811 $b ABA008
999    __
$a ok $b bmc $g 1239016 $s 984248
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 31 $c 3 $d 488-496 $e 20170126 $i 1099-1573 $m PTR. Phytotherapy research $n Phytother Res $x MED00003832
LZP    __
$a Pubmed-20170720

Find record

Citation metrics

Archiving options